Drug factory · FDA FEI 3015287114
Millicent Pharma (NI) Limited
Old Belfast Road Millbrook, Larne, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Mar 6, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2020: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Estradiol | Makes it | Millicent US, Inc. | 72495-201, 72495-202, 72495-301 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 6, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 18, 2020 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture; pack.